Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Annovis Bio, Inc. (ANVS)

NYSE

$1,40

$+0,01

(+0,72%)

Pre-Market

Annovis Bio, Inc. (ANVS) Live Price Chart

Last updated: ⁦2026-09-04 13:19:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Annovis Bio, Inc. (ANVS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,40, with a market capitalization of $72,43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,32 to $5,50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$72,43M
Open	$1,40
Day's High	$132,00
Day's Low	$1,11
Previous Close	$1,38
Volume	729,00
Average Volume	--
P/E Ratio	--
52-Week High	$5,50
52-Week Low	$1,32
Dividend Yield	--
Earnings Date	--

Annovis Bio, Inc. (ANVS) Pre-Market Stock Price

Annovis Bio, Inc. (ANVS) is trading at $1,40 in pre-market trading as of 2026-09-04 13:15:00, up 1,45% ($0,02) from the previous close of $1,38

Pre-market trading shows how investors are pricing ANVS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Annovis Bio, Inc. (ANVS) 7-Day Stock Price Change

Over the past seven days, Annovis Bio, Inc. (ANVS) moved from $1,72 to $1,40, representing a decline of 18,60% ($0,32).

The stock traded between $1,40 and $1,40 during the period. The latest price is -- of the 7-day range, indicating strong downward.

The average daily volume was 1,38 million shares, up versus the previous seven-day period, indicating higher trading activity.

ANVS 52-Week Price Position

Position in Range: 1,9%

52W Low$1,32

52W High$5,50

ANVS is currently trading at $1,40, placing it 1,9% of the way from its 52-week low of $1,32 to its 52-week high of $5,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Annovis Bio, Inc. (ANVS)?

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Annovis Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	7
Exchange	NYSE
Company Website	https://www.annovisbio.com

How to Buy Annovis Bio, Inc. (ANVS) Stock on MEXC

Eligible investors can buy real shares of Annovis Bio, Inc. (ANVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ANVS and Place Your Order

Open the RealStocks trading page and search for ANVS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Annovis Bio, Inc. (ANVS) stock price today?

Annovis Bio, Inc. (ANVS) is currently trading at $ 1,40, up 1,45% ($0,02) from the previous close of $ 1,38. Intraday prices update in real time during regular trading hours.

2.Is ANVS stock going up or down today?

As of 2026-09-04 13:15:00, ANVS is trading at $ 1,40, up 1,45% ($0,02) from its previous close of $ 1,38. The stock has traded between $ 1,11 and $ 132,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ANVS pre-market price?

As of 2026-09-04 13:15:00, ANVS is trading at $ 1,40 in pre-market trading, up 1,45% ($0,02) from the previous close of $ 1,38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ANVS after-hours price?

As of 2026-09-04 13:15:00, ANVS is trading at -- in after-hours trading, -- from the regular-session close of $ 1,38. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ANVS stock trading now?

ANVS trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ANVS sit relative to its 52-week high and low?

Over the past 52 weeks, ANVS has traded between a low of $ 1,32 and a high of $ 5,50. At $ 1,40, the stock is positioned 1,9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Annovis Bio, Inc. in?

Annovis Bio, Inc. (ANVS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Annovis Bio, Inc.'s market capitalization and where is it listed?

Annovis Bio, Inc. is listed on the NYSE exchange with a market capitalization of $ 72,43M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ANVS valued in terms of P/E ratio and EPS?

ANVS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,16. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Annovis Bio, Inc. pay a dividend?

Annovis Bio, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.